Or, register now

31 Studies on Vaccine Efficacy that Raise Doubts on Vaccine Mandates

By Grabien Staff
Contributors: 2
Items: 34
Summary Date Source
COVID-19 vaccine surveillance report Week 42 UK Health Security Agency
Download An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 202 07/29/2021 Eurosurveillance
Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2 08/01/2021 NIH National Library of Medicine
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021 08/06/2021 NIH National Library of Medicine
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence 08/21/2021 NIH National Library of Medicine
Hospitalisation among vaccine breakthrough COVID-19 infections 09/07/2021 The Lancet Infectious Disease
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021 09/17/2021 CDC
Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States 09/30/2021 European Journal of Epidemiology
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021 09/30/2021 Eurosurveillance
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce 09/30/2021 The New England Journal of Medicine
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months 10/06/2021 The New England Journal of Medicine
Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam 10/11/2021 The Lancet
Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study 10/25/2021 The Lancet
Waning Immunity after the BNT162b2 Vaccine in Israel 10/27/2021 The New England Journal of Medicine
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study 10/29/2021 The Lancet Infectious Disease
https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1.full 11/01/2021 Cold Spring harbor Laboratory
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant 11/01/2021 Cold Spring Harbor Laboratory
Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant 11/01/2021 Cold Spring Harbor Laboratory
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar 11/01/2021 Cold Spring Harbor Laboratory
Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent - Wisconsin, July 2021 11/01/2021 Cold Spring Harbor Laboratory
Durability of immune responses to the BNT162b2 mRNA vaccine 11/01/2021 Cold Spring Harbor Laboratory
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? 11/01/2021 Journal of Infection
The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission 11/01/2021 Cold Spring Harbor Laboratory
Significant reduction in humoral immunity among healthcare workers and nursing home residents 6 months after COVID-19 BNT162b2 mRNA vaccination 11/01/2021 Cold Spring Harbor Laboratory
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection 11/01/2021 Cold Spring Harbor Laboratory
The longitudinal kinetics of antibodies in COVID-19 recovered patients over 14 months 11/01/2021 Cold Spring Harbor Laboratory
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2 11/02/2021 Nature Medicine
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 11/05/2021 CDC Centers for Disease control and prevention
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 11/12/2021 Cold Spring Harbor Laboratory
Increased risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals 11/24/2021 Cold Spring Harbor Laboratory
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2 11/30/2021 Taylor & Francis Online
Vaccines Are Perfectly Safe, Unless You’re Young and Swedish 12/07/2021 Epoch Times
“Of the 4,526 children, aged 6 months to 4 years, who participated in Pfizer's trial, 3,000 didn't make it to the end of the trial.” 06/28/2022 Mercola
Higher vaccine rates associated with greater rise in hospitalization 07/13/2022 bad cattitude
Like our work? Support the cause.